The species of Ebola virus causing an outbreak in Congo that has killed nearly 120 people is less common than other Ebola viruses, which is complicating the response because there are no specific treatments or vaccines. “There’s nothing even close to ready for clinical trials,” said Dr. Celine Gounder, an infectious disease specialist and epidemiologist
